“Down Staging of Cirrhosis in All Cirrhotic Patients With HCV Genotype 3-a Infection, Treated With 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin”. Medical Forum Monthly 29, no. 3 (May 2, 2024). Accessed November 16, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/2891.